Home › Funds › ORBIMED ADVISORS LLC › CAI
ORBIMED ADVISORS LLC position in CAI
CARIS LIFE SCIENCES INC · Health Care
ORBIMED ADVISORS LLC reported holding 2,806,811 shares of CAI (CARIS LIFE SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$50.0M, representing 1.01% of its reported portfolio and ranking #32 among its reported holdings. ORBIMED ADVISORS LLC has disclosed CAI holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's CAI position evolved
ORBIMED ADVISORS LLC first disclosed a stake in CAI in Q2 2025 at 3,034,858 shares (US$81.1M). The position peaked in Q3 2025 at 3,034,858 shares, worth US$91.8M. Across 5 filings, ORBIMED ADVISORS LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,806,811 shares valued at US$50.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 3.03M | $81.09M | New |
| Q3 2025 | 3.03M | $91.80M | Hold |
| Q4 2025 | 3.12M | $84.07M | Add |
| Q1 2026 | 2.81M | $50.19M | Reduce |
| Q2 2026 | 2.81M | $50.02M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAI and 13F data
CAI (CARIS LIFE SCIENCES INC) is a Health Care company. 53 other funds we track also report a position in CAI — the largest reported positions include J. H. Whitney Equity Partners VI, LLC (US$200.6M), Coatue Management (US$175.0M), COATUE MANAGEMENT LLC (US$175.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAI
- J. H. Whitney Equity Partners VI, LLC 11.26M sh · $200.59M · Q2 2026
- Coatue Management 9.82M sh · $174.99M · Q2 2026
- COATUE MANAGEMENT LLC 9.82M sh · $174.99M · Q2 2026
- BRAIDWELL LP 8.26M sh · $147.12M · Q2 2026
- PointState Capital LP 6.83M sh · $121.69M · Q2 2026
- MAK CAPITAL ONE LLC 1.94M sh · $34.52M · Q2 2026
- Duquesne Family Office LLC 1.89M sh · $33.76M · Q2 2026
- ZEVENBERGEN CAPITAL INVESTMENTS LLC 719.60K sh · $22.04M · Q3 2026
- MENLO ADVISORS LLC 300.52K sh · $5.36M · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held CAI?
ORBIMED ADVISORS LLC has disclosed CAI holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is ORBIMED ADVISORS LLC's current position in CAI?
As of Q2 2026, ORBIMED ADVISORS LLC holds 2.81M shares of CAI (CARIS LIFE SCIENCES INC), valued at $50.02M, representing 1.01% of its reported portfolio and ranking #32.
Has ORBIMED ADVISORS LLC been buying or selling CAI?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC held unchanged its position in CAI. The position peaked in Q3 2025 at 3.03M shares.
Which other funds hold CAI?
Other major institutional holders of CAI include J. H. Whitney Equity Partners VI, LLC, Coatue Management, COATUE MANAGEMENT LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.